Abstract

Aim: The present study investigated the effect of IABPD in clinical outcomes of percutaneous coronary intervention (PCI) in patients with coronary artery diseases.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Long-Term Outcome of Left Main Percutaneous Coronary Intervention in Patients with Coronary Artery Disease
A Marushko ... S Kuzmenko
Ukrainian Journal of Cardiovascular Surgery | VOL. -
A Marushko, et. al.A Marushko ... S Kuzmenko
25 Feb 2020
Chronic Kidney Disease and Post-Percutaneous Coronary Intervention Mortality in Patients With Left Main and Equivalent Coronary Artery Disease.
Neil Yager ... Mikhail Torosoff
Texas Heart Institute journal | VOL. 49
Neil Yager, et. al.Neil Yager ... Mikhail Torosoff
01 Sep 2022
Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis
Sachin S Goel ... Tarique Zaman
Circulation | VOL. 125
Sachin S Goel, et. al.Sachin S Goel ... Tarique Zaman
28 Feb 2012
Timing and Outcomes of Percutaneous Coronary Intervention in Patients Who Underwent Transcatheter Aortic Valve Implantation
Tomoki Ochiai ... Raj Makkar
The American Journal of Cardiology | VOL. 125
Tomoki Ochiai, et. al.Tomoki Ochiai ... Raj Makkar
08 Feb 2020
View more papers

More From: Atherosclerosis

Paper Title
Journal
Date
Author
Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype
Jordan M Kraaijenhof ... Dominique P.V De Kleijn
Atherosclerosis | VOL. -
Jordan M Kraaijenhof, et. al.Jordan M Kraaijenhof ... Dominique P.V De Kleijn
01 Jul 2024
MiR-1290 induces endothelial-to-mesenchymal transition and promotes vascular restenosis after angioplasty by targeting FGF2
Shuning Han ... Mingjin Guo
Atherosclerosis | VOL. -
Shuning Han, et. al.Shuning Han ... Mingjin Guo
01 Jul 2024
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials
Pascal M Burger ... Frank L.J Visseren
Atherosclerosis | VOL. -
Pascal M Burger, et. al.Pascal M Burger ... Frank L.J Visseren
01 Jul 2024
Enhancement of high-density lipoprotein-associated protease inhibitor activity prevents atherosclerosis progression
Maura Mobilia ... Scott M Gordon
Atherosclerosis | VOL. -
Maura Mobilia, et. al.Maura Mobilia ... Scott M Gordon
01 Jul 2024
View more papers